FDA’s “Mini-Sentinel” pilot program, the Agency’s first step towards building a nationwide rapid-response electronic safety surveillance system for drugs and other medical products (which will be called the Sentinel System), is now up and running, enabling scientists to evaluate safety questions far more rapidly than using traditional channels.
For more details, visit the FDA's Sentinel Initiative website.
UCM268035.pdf: - Enviado mediante la barra Google
0 comentarios:
Publicar un comentario en la entrada